Home
Conditions
Primary Myelofibrosis

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

457 public trials 86 recruiting studies

Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

NCT07362225

Conditions: Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
Locations: MPN Research Foundation Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Selumetinib and Azacitidine in High Risk Chronic Blood Cancers

NCT03326310

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Recruiting

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

NCT06541249

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations: Ruttenberg Treatment Center New York, United States

View Trial Details

Recruiting

A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

NCT06122831

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Guangxi Zhuang Autonomous Region People's Hospital Nanning, Guangxi, China

Cangzhou People's Hosipital Cangzhou, Hebei, China

Affiliated Hospital of Chengde Medical College Chengde, Hebei, China

View all 22 locations

View Trial Details

Recruiting

Two Step Haplo With Radiation Conditioning

NCT05031897

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-Cell Leukemia/Lymphoma, +61 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadephia, Pennsylvania, United States

View Trial Details

Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations: Massive Bio SYNERGY-AI site Birmingham, Alabama, United States

Massive Bio SYNERGY-AI site Mobile, Alabama, United States

Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States

Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States

View all 68 locations

View Trial Details

Recruiting

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

NCT01137643

Conditions: Amyloidosis, Anemia, Anemia, Aplastic, +98 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

Q702 for the Treatment of Patients With Hematologic Malignancies

NCT06712810

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

A Study of GLB-001 in Patients With Myeloid Malignancies

NCT06378437

Conditions: Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
Locations: The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China

China-Japan Friendship Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

The First Hospital of Hebei Medical Universtiy Shijiazhuang, Hebei, China

View all 14 locations

View Trial Details

Recruiting

Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in Myeloproliferative Neoplasms (EpiC)

NCT06022328

Conditions: Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +10 more
Locations: CHU de Bordeaux, service Hématologie Biologique Bordeaux, France

View Trial Details

Primary Myelofibrosis

Primary Myelofibrosis trial results

Related conditions